HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael L Alosco Selected Research

Chronic Traumatic Encephalopathy

1/2022A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease.
1/2022MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis.
1/2022Association of APOE Genotypes and Chronic Traumatic Encephalopathy.
12/2021Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project.
10/2021Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology.
1/2021Neuroimaging Biomarkers of Chronic Traumatic Encephalopathy: Targets for the Academic Memory Disorders Clinic.
1/2021National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome.
1/2020Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy.
1/2018Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration.
10/2017Magnetic Resonance Spectroscopy as a Biomarker for Chronic Traumatic Encephalopathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael L Alosco Research Topics

Disease

16Cognitive Dysfunction
01/2021 - 09/2010
14Alzheimer Disease (Alzheimer's Disease)
10/2022 - 06/2010
12Chronic Traumatic Encephalopathy
01/2022 - 01/2017
9Dementia (Dementias)
08/2022 - 01/2014
9Heart Failure
01/2016 - 01/2012
6Traumatic Brain Injuries (Traumatic Brain Injury)
02/2022 - 01/2019
5Obesity
01/2015 - 01/2014
3Atrophy
12/2021 - 09/2010
3Inflammation (Inflammations)
07/2021 - 01/2015
2Tauopathies
01/2020 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
12/2014 - 12/2013
2Hypertension (High Blood Pressure)
12/2014 - 08/2014
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022
1Neurobehavioral Manifestations
10/2021
1Nervous System Diseases (Neurological Disorders)
01/2021
1Memory Disorders (Memory Loss)
01/2021
1Overweight
01/2020
1Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018
1Neuroinflammatory Diseases
11/2018
1Parkinsonian Disorders (Parkinsonism)
01/2018
1Weight Loss (Weight Reduction)
07/2015
1Binge-Eating Disorder (Binge Eating Disorder)
12/2014
1Stroke (Strokes)
11/2014
1Type 2 Diabetes Mellitus (MODY)
06/2014
1Epilepsy (Aura)
02/2011

Drug/Important Bio-Agent (IBA)

13Biomarkers (Surrogate Marker)IBA
10/2022 - 01/2017
4Amyloid (Amyloid Fibrils)IBA
01/2022 - 01/2018
3Amyloid beta-PeptidesIBA
01/2022 - 01/2019
3Apolipoproteins E (ApoE)IBA
01/2022 - 09/2010
3TESIBA
12/2021 - 01/2021
3ApolipoproteinsIBA
10/2021 - 09/2010
3Proteins (Proteins, Gene)FDA Link
11/2018 - 01/2017
2Threonine (L-Threonine)FDA Link
10/2022 - 06/2010
2LeptinIBA
01/2020 - 01/2015
1MicroRNAs (MicroRNA)IBA
01/2022
1Biological ProductsIBA
12/2021
1Peptides (Polypeptides)IBA
07/2021
1C-Reactive ProteinIBA
07/2021
1Pharmaceutical PreparationsIBA
07/2021
1RNA Precursors (Precursor, mRNA)IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Protein Isoforms (Isoforms)IBA
01/2020
1florbetapirIBA
01/2019
17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2019
1Indicators and Reagents (Reagents)IBA
04/2017
1Blood Proteins (Serum Proteins)IBA
01/2017
1GhrelinIBA
01/2015
1CholesterolIBA
12/2014
1Antihypertensive Agents (Antihypertensives)IBA
08/2014
1Brain-Derived Neurotrophic Factor (BDNF)IBA
12/2013
1Genetic Markers (Genetic Marker)IBA
12/2013
1Glucose (Dextrose)FDA LinkGeneric
01/2013
1BuffersIBA
01/2012
1Flavin-Adenine Dinucleotide (FAD)IBA
02/2011
1amyloid beta-protein (1-42)IBA
06/2010

Therapy/Procedure

11Bariatric Surgery
07/2015 - 01/2014
6Activities of Daily Living (ADL)
01/2016 - 01/2012
3Glycemic Control
07/2015 - 06/2014
3Cardiac Rehabilitation
11/2014 - 04/2013